LI
ALDR

LMCG Investments’s Alder Biopharmaceuticals ALDR Stock Holding History

LMCG Investments’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$2.54M Buy
+77,532
New +$3.3M 0.05% 352

Other funds holding ALDR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

LMCG Investments's ALDR Position: Q3 2015 in Review

LMCG Investments opened a new position in Alder Biopharmaceuticals (ALDR) in Q3 2015: 77,532 shares worth $2.54M. The stake represents 0.05% of the portfolio and ranks #352 among its holdings.

140 funds tracked by Wall St. Rank hold ALDR as of Q3 2015.

  • LMCG Investments held 77,532 shares of Alder Biopharmaceuticals worth $2.54M as of Q3 2015.
  • Alder Biopharmaceuticals was a new LMCG Investments position in Q3 2015.
  • Alder Biopharmaceuticals made up 0.05% of LMCG Investments's portfolio in Q3 2015, its #352 holding.
  • 140 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q3 2015.

Based on LMCG Investments's 13F filing for Q3 2015, filed 4 Nov 2015.